|
MUC1 Peptide Vaccine Clinical Trials
1 actively recruiting trial across 1 location
Pittsburgh, Pennsylvania1 trial
Prototype DAA/TAA Vaccine Targeting MUC1 for Immune Interception and Prevention in Ductal Carcinoma In Situ
UPMC Magee Womens Hospital
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.